Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.44 |
| ▸ | KDM1A | O60341 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | FBP1 | P09467 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL629156 | 1.00 | LMNA (0.66) | LMNATDP1ALDH1A1TSHRAKR1C3 | |
| SCHEMBL3337166 | 1.00 | LMNA (0.66) | LMNATDP1ALDH1A1TSHRAKR1C3 | |
| SCHEMBL28363417 | 0.86 | LMNA (0.51) | LMNATDP1ALDH1A1TSHRAKR1C3 | |
| SCHEMBL17444731 | 0.84 | LMNA (0.77) | LMNATDP1ALDH1A1TSHRAKR1C3 | |
| SCHEMBL20424858 | 0.84 | LMNA (0.77) | LMNATDP1ALDH1A1TSHRAKR1C3 | |
| SCHEMBL24352196 | 0.83 | ALDH1A1 (0.61) | LMNATDP1ALDH1A1TSHRAKR1C3 | |
| SCHEMBL22423775 | 0.82 | CYP2A6 (0.46) | LMNATDP1ALDH1A1TSHRAKR1C3 | |
| SCHEMBL574972 | 0.82 | CYP2A6 (0.46) | LMNATDP1ALDH1A1TSHRAKR1C3 | |
| SCHEMBL574971 | 0.82 | CYP2A6 (0.46) | LMNATDP1ALDH1A1TSHRAKR1C3 | |
| SCHEMBL113478 | 0.81 | LMNA (0.90) | LMNATDP1ALDH1A1TSHRAKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118061742-A | Vehicle-mounted fragrance and preparation method thereof | 广州汽车集团股份有限公司 | 2024-05-24 | — | — | CN | claimed |
| US-4172955-A | REARRANGMENT OF A CINNAMALDEHYDE TO A PHENYLMALONDIALDEHYDE TETRAMETHYL DISACETAL | EMERY INDUSTRIES, INC. (US) | 1979-10-30 | — | — | US | claimed |
| EP-4665713-A1 | NEMATICIDAL COMPOUNDS, THEIR COMPOSITION AND USE THEREOF | Bhukhanwala, Komal (IN) | 2025-12-24 | — | — | EP | disclosed |
| WO-2024171230-A1 | NEMATICIDAL COMPOUNDS, THEIR COMPOSITION AND USE THEREOF | BHUKHANWALA KOMAL (IN) | 2024-08-22 | — | — | WO | disclosed |
| CN-118061742-A | Vehicle-mounted fragrance and preparation method thereof | 广州汽车集团股份有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-118061742-A | Vehicle-mounted fragrance and preparation method thereof | 广州汽车集团股份有限公司 | 2024-05-24 | — | — | CN | disclosed |
| US-11891703-B2 | Corrosion inhibition package | DORF KETAL CHEMICALS FZE (AE) | 2024-02-06 | — | — | US | disclosed |
| EP-3532459-B1 | LSD1 INHIBITORS AND MEDICAL USES THEREOF | CONSTELLATION PHARMACEUTICALS INC (US) | 2023-08-02 | — | — | EP | disclosed |
| EP-3532459-B1 | LSD1 INHIBITORS AND MEDICAL USES THEREOF | CONSTELLATION PHARMACEUTICALS INC (US) | 2023-08-02 | — | — | EP | disclosed |
| US-11547695-B2 | LSD1 inhibitors and medical uses thereof | CONSTELLATION PHARMACEUTICALS, INC. (US) | 2023-01-10 | — | — | US | disclosed |
| US-11547695-B2 | LSD1 inhibitors and medical uses thereof | CONSTELLATION PHARMACEUTICALS, INC. (US) | 2023-01-10 | — | — | US | disclosed |
| US-4520176-A | DILUENT, DURABLE PRESS RESIN CONTAINING AN AMINOPLAST AND AN ALOEHYDE | SWS SILICONES CORPORATION (US) | 1985-05-28 | — | — | US | disclosed |
| EP-0107799-A1 | Durable press resin compositions | SWS Silicones Corporation (US) | 1984-05-09 | — | — | EP | disclosed |
| EP-0017893-B1 | PROCESS FOR THE PREPARATION OF HETEROCYCLIC TERTIARY ARALKYL AMINES | BASF Aktiengesellschaft (DE) | 1982-03-24 | — | — | EP | disclosed |
| US-4283534-A | Reductive alkylation of nitrogen heterocycles | BASF AKTIENGESELLSCHAFT (DE) | 1981-08-11 | — | — | US | disclosed |
| US-4237306-A | ELECTROPHILIC REACTIONS WITH ALKYL ARYL KETONES TO PRODUCE METHYL ARYL ALKANOATES | EMERY INDUSTRIES, INC. (US) | 1980-12-02 | — | — | US | disclosed |
| EP-0017893-A1 | Process for the preparation of heterocyclic tertiary aralkyl amines | BASF Aktiengesellschaft (DE) | 1980-10-29 | — | — | EP | disclosed |
| US-4172955-A | REARRANGMENT OF A CINNAMALDEHYDE TO A PHENYLMALONDIALDEHYDE TETRAMETHYL DISACETAL | EMERY INDUSTRIES, INC. (US) | 1979-10-30 | — | — | US | disclosed |
| US-4087549-A | Sulphonic acid containing indenyl derivatives | MERCK & CO., INC. (US) | 1978-05-02 | — | — | US | disclosed |
| US-4067823-A | Thallium(III) reagents supported on montmorillonite clay minerals and oxythallation processes for utilizing same | EMERY INDUSTRIES, INC. (US) | 1978-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11547695-B2 | LSD1 inhibitors and medical uses thereof | KDM1B, KDM1A, KDM2A | LMNA 1502/4885TDP1 490/4885ALDH1A1 163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.